BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yanai A, Sakamoto K, Akanuma M, Ogura K, Maeda S. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. World J Gastrointest Pharmacol Ther 2012; 3(1): 1-6 [PMID: 22408744 DOI: 10.4292/wjgpt.v3.i1.1]
URL: https://www.wjgnet.com/2150-5349/full/v3/i1/1.htm
Number Citing Articles
1
Javier Molina-Infante, David Y. Graham. Helicobacter pylori Research2016; : 471 doi: 10.1007/978-4-431-55936-8_20
2
Richard J.M. Ingram, Krish Ragunath, John C. Atherton. Yamada' s Textbook of Gastroenterology2015; : 1032 doi: 10.1002/9781118512074.ch56
3
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pyloriGastroenterología y Hepatología 2016; 39(10): 697 doi: 10.1016/j.gastrohep.2016.05.003
4
Mei-Jyh Chen, Chien-Chuan Chen, Yen-Nien Chen, Chieh-Chang Chen, Yu-Jen Fang, Jaw-Town Lin, Ming-Shiang Wu, Jyh-Ming Liou. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori InfectionAmerican Journal of Gastroenterology 2018; 113(10): 1444 doi: 10.1038/s41395-018-0217-2
5
Bojan Tepes, Anthony O'Connor, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2012Helicobacter 2012; 17(s1): 36 doi: 10.1111/j.1523-5378.2012.00981.x
6
Chi-Tan Hu. High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection – A review of the strengths, weaknesses, and proposed solutionsTzu Chi Medical Journal 2022; 34(3): 303 doi: 10.4103/tcmj.tcmj_185_21
7
Xiao-Min Liao, Gao-Hui Nong, Mei-Zu Chen, Xue-Ping Huang, Yun-Yan Cong, Yi-Ying Huang, Bai-He Wu, Jin-Qi Wei. Modified sequential therapy <italic>vs</italic> quadruple therapy as initial therapy in patients with <italic>Helicobacter</italic> infectionWorld Journal of Gastroenterology 2015; 21(20): 6310-6316 doi: 10.3748/wjg.v21.i20.6310
8
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Spanish Consensus Conference on Helicobacter pylori infection treatmentGastroenterología y Hepatología (English Edition) 2016; 39(10): 697 doi: 10.1016/j.gastre.2016.11.007
9
Jason Ferreira, Steven F. Moss. Current Paradigm and Future Directions for Treatment of Helicobacter pylori InfectionCurrent Treatment Options in Gastroenterology 2014; 12(4): 373 doi: 10.1007/s11938-014-0027-6
10
Hassan Seddik, Samir Ahid, Tarek El Adioui, Fatim-Zohra El Hamdi, Mohammed Hassar, Redouane Abouqal, Yahia Cherrah, Ahmed Benkirane. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized studyEuropean Journal of Clinical Pharmacology 2013; 69(9): 1709 doi: 10.1007/s00228-013-1524-6
11
Hassan Ali Metanat, Seyed Mohammad Valizadeh, Hafez Fakheri, Iradj Maleki, Tarang Taghvaei, Vahid Hosseini, Zohreh Bari. Comparison Between 10‐ and 14‐Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical TrialHelicobacter 2015; 20(4): 299 doi: 10.1111/hel.12202
12
Javier Molina-Infante, Akiko Shiotani. Practical Aspects in Choosing a Helicobacter pylori TherapyGastroenterology Clinics of North America 2015; 44(3): 519 doi: 10.1016/j.gtc.2015.05.004
13
Javier Molina-Infante. Helicobacter pylori2016; : 237 doi: 10.1007/978-4-431-55705-0_15
14
Theodore Rokkas, Javier P. Gisbert, Peter Malfertheiner, Yaron Niv, Antonio Gasbarrini, Marcis Leja, Francis Megraud, Colm O’Morain, David Y. Graham. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysisGastroenterology 2021; 161(2): 495 doi: 10.1053/j.gastro.2021.04.012
15
Fernando Macías‐García, Iria Bastón‐Rey, Daniel de la Iglesia‐García, Cristina Calviño‐Suárez, Laura Nieto‐García, Juan Enrique Domínguez‐Muñoz. Bismuth‐containing quadruple therapy versus concomitant quadruple therapy as first‐line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross‐sectional, comparative, open trialHelicobacter 2019; 24(1) doi: 10.1111/hel.12546
16
Javier Molina-Infante, Javier P Gisbert. Optimizing clarithromycin-containing therapy for <italic>Helicobacter pylori</italic> in the era of antibiotic resistanceWorld Journal of Gastroenterology 2014; 20(30): 10338-10347 doi: 10.3748/wjg.v20.i30.10338
17
Anthony O'Connor, Javier Molina‐Infante, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori Infection 2013Helicobacter 2013; 18(s1): 58 doi: 10.1111/hel.12075
18
Muhammad Miftahussurur, Yoshio Yamaoka. Helicobacter pylori Research2016; : 519 doi: 10.1007/978-4-431-55936-8_23
19
Yoen‐Young Chuah, Deng‐Chyang Wu, Seng‐Kee Chuah, Jyh‐Chin Yang, Tzong‐Hsi Lee, Hong‐Zen Yeh, Chan‐Lin Chen, Yu‐Hwa Liu, Ping‐I Hsu. Real‐world practice and Expectation of Asia‐Pacific physicians and patients in Helicobacter Pylori eradication (REAP‐HP Survey)Helicobacter 2017; 22(3) doi: 10.1111/hel.12380
20
Shachish Doctor, Philip Abraham, Devendra Desai, Pavan Dhoble, Tarun Gupta, Anand Joshi. Ten-day concomitant and sequential therapy for Helicobacter pylori effective in region with high antibiotic resistance ratesIndian Journal of Gastroenterology 2022; 41(6): 627 doi: 10.1007/s12664-022-01272-1
21
Xin Yan Zhu, Fei Liu. Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapyJournal of Digestive Diseases 2017; 18(4): 195 doi: 10.1111/1751-2980.12466
22
Ala I Sharara, Fayez S Sarkis, Mustapha M El-Halabi, Ahmad Malli, Nabil M Mansour, Cecilio Azar, Mohamad A Eloubeidi, Fadi H Mourad, Kassem Barada, Ismail Sukkarieh. Challenging the dogma: a randomized trial of standard vs. half‐dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infectionUnited European Gastroenterology Journal 2014; 2(3): 179 doi: 10.1177/2050640614530919
23
Muhammad Miftahussurur, Yoshio Yamaoka. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian PerspectiveMolecules 2015; 20(4): 6068 doi: 10.3390/molecules20046068
24
Yasser Abu-Safieh, Hanin Yamin. Sequential and concomitant non-bismuth quadruple therapies are ineffective for &lt;i&gt;H. pylori&lt;/i&gt; eradication in Palestine. A randomized trialOpen Journal of Gastroenterology 2012; 2(04): 177 doi: 10.4236/ojgas.2012.24034
25
Kosuke Sakitani, Yoshihiro Hirata, Nobumi Suzuki, Satoki Shichijo, Ayako Yanai, Takako Serizawa, Kei Sakamoto, Masao Akanuma, Shin Maeda, Yutaka Yamaji, Yasuhiko Iwamoto, Shoji Kawazu, Kazuhiko Koike. Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patientsBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0377-0